Q4FY26 - Strong revenue growth and margin improvement - Revenues were up ~20% YoY to 370 crore driven by power brands of Neurobion Forte (Multivitamins), Livogen (Iron compounds), and Polybion (Vitamin B complex) but pulled down by de-growth in Evion (Vitamin E) and Nasivion (nasal decongestant). EBITDA grew ~67% YoY to ~136 crore and margins increased 1058 bps YoY to 36.6% mainly due to 31% increase in...